Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MET | P08581 | 1/20 | 0.35 |
| ▸ | TOP1 | P11387 | 4/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17014605 | 0.88 | CCR1 (0.42) | KDM4EMAPK1ALDH1A1MAPTLMNA | |
| SCHEMBL17014604 | 0.88 | CCR1 (0.42) | KDM4EMAPK1ALDH1A1MAPTLMNA | |
| SCHEMBL16658502 | 0.85 | GRM5 (0.41) | PIK3CAKDM4EMAPK1ALDH1A1MAPT | |
| SCHEMBL2733743 | 0.84 | GRM5 (0.41) | KDM4EMAPK1ALDH1A1MAPTLMNA | |
| SCHEMBL16658479 | 0.82 | GRM5 (0.43) | KDM4EMAPK1ALDH1A1LMNACCR1 | |
| SCHEMBL16658498 | 0.81 | GRM5 (0.40) | KDM4EMAPK1ALDH1A1LMNATOP1 | |
| SCHEMBL20652907 | 0.79 | MAPT (0.32) | KDM4EMAPK1ALDH1A1MAPTMEN1 | |
| SCHEMBL19618368 | 0.79 | DHODH (0.51) | PIK3CAKDM4EMAPK1ALDH1A1MAPT | |
| SCHEMBL19050388 | 0.78 | PIK3CA (0.40) | PIK3CAKDM4EMAPK1ALDH1A1MAPT | |
| SCHEMBL76389 | 0.78 | ALDH1A1 (0.44) | KDM4EMAPK1ALDH1A1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10680182-B2 | Fluoranthene compound, and organic electronic device comprising same | LG CHEM, LTD. (KR) | 2020-06-09 | — | — | US | disclosed |
| EP-2924020-B1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-01-16 | — | — | EP | disclosed |
| EP-2924020-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2015-09-30 | — | — | EP | disclosed |
| US-20150236273-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2015-08-20 | — | — | US | disclosed |
| US-20150236273-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10680182-B2 | Fluoranthene compound, and organic electronic device comprising same | AFF2, ESR1, AFF4 | PIK3CA 3720/4885KDM4E 870/4885MAPK1 1899/4885 |
| US-20150236273-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | AFF2, ESR1, AFF4 | PIK3CA 3720/4885KDM4E 870/4885MAPK1 1899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.